Boosting maternal and neonatal anti-SARS-CoV-2 humoral immunity using a third mRNA vaccine dose
Description
CONCLUSION: The third boosting dose of mRNA Pfizer BNT162b2 vaccine augmented maternal and neonatal immunity with mild side effects. These data provide evidence to bolster clinical and public health guidance, reassure patients, and increase vaccine
